Announcements Trials
Browse Landscape

Phase

Phase 2 138Phase 1 113Phase 1/2 48Phase NA 38Phase 3 23Phase EARLY_PHASE1 9Phase 2/3 5Phase 4 3

Status

Completed 21Unknown 5Terminated 3Recruiting 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 29Genitourinary 23Thoracic 20Breast 19Other hematologic neoplasm 16Lymphoid 14Dermatologic 10Gynecologic 8Classical hematology 8Head & Neck 6Myeloid 5CNS 4Tumor-Agnostic 3Sarcoma 3Other 3Plasma cell 2Endocrine 2Other solid neoplasm 1Other neoplasm 1NET 1

Conditions

Sarcoma 1Rhabdomyosarcoma, Alveolar 1Psoriasis 1Pain, Intractable 1Neoplasms 1Bone Neoplasms 1

Interventions

Tranexamic Acid 1Pregabalin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Sarcoma × Clear all
NCT04347122 2025-05-21

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

University of Kansas Medical Center

Phase 4 Terminated
12 enrolled 6 charts
Sarcoma

Sarcoma

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated
152 enrolled 14 charts
Sarcoma

Bone Neoplasms, Neoplasms, Pain, Intractable

NCT00924950 2019-04-18

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

University of California, San Francisco

Phase 4 Terminated
35 enrolled 3 charts
Sarcoma

Psoriasis, Rhabdomyosarcoma, Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡